MedAlliance announced today that it enrolled the first patient in an erectile dysfunction (ED) feasibility study with its drug-eluting balloon (DEB). Nyon, Switzerland-based MedAlliance’s first patient was enrolled in the trial at the University of Rome Tor Vergata, Italy, under the direction of principal investigator Giuseppe Sangiorgi, a … [Read more...] about MedAlliance enrolls first patient in drug-eluting balloon trial for erectile dysfunction
MedAlliance
MedAlliance nabs FDA breakthrough nod for drug-eluting coronary balloon
MedAlliance today said it received FDA breakthrough device designation for its Selution SLR sustained limus release drug-eluting balloon catheter. Selution SLR is designed to treat atherosclerotic lesions in native coronary arteries. The breakthrough designation was awarded for its design of improving luminal diameter in patients with … [Read more...] about MedAlliance nabs FDA breakthrough nod for drug-eluting coronary balloon
